methylprednisolone has been researched along with artemether in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Amore, A; Calitri, C; Camilla, R; Garazzino, S; Peruzzi, L; Tovo, PA | 1 |
3 other study(ies) available for methylprednisolone and artemether
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
"Collateral" effect of artemether in an atypical kidney involvement by Plasmodium falciparum malaria: a case report.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Artemether; Artemisinins; Atovaquone; Body Temperature; Cote d'Ivoire; Creatinine; Cyclophosphamide; Drug Combinations; Female; Glomerular Filtration Rate; Humans; Immunosuppression Therapy; Kidney; Malaria, Falciparum; Methylprednisolone; Proguanil; Proteinuria; Treatment Outcome | 2014 |